Karen Beckman to Anti-Arrhythmia Agents
This is a "connection" page, showing publications Karen Beckman has written about Anti-Arrhythmia Agents.
Connection Strength
0.263
-
Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Cardiovasc Electrophysiol. 2003 Sep; 14(9):940-8.
Score: 0.053
-
Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. Am J Cardiol. 2003 Apr 01; 91(7):812-6.
Score: 0.051
-
Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and an AVID substudy. Antiarrhythmics Versus Implantable Defibrillators. J Cardiovasc Electrophysiol. 2001 Sep; 12(9):996-1001.
Score: 0.046
-
Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation. 2001 Apr 24; 103(16):2066-71.
Score: 0.045
-
Acute hemodynamic effects of intravenous ibutilide in patients with or without reduced left ventricular function. Am J Cardiol. 1997 Aug 15; 80(4):458-63.
Score: 0.035
-
A simple method of monitoring antiarrhythmic drugs during short- and long-term therapy. Am J Cardiol. 1989 May 15; 63(17):1273-5.
Score: 0.020
-
Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J. 2005 Apr; 149(4):657-63.
Score: 0.015